Role of exercise in rehabilitation of cancer survivors

Pediatric Blood and Cancer

Volumn 44, Issue 7, 2005, Pages 595-599

  Braith, Randy W ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Aerobic exercise; Cardiac rehabilitation; Resistance training

Indexed keywords

ANTHRACYCLINE;

ADOLESCENT; CANCER DIAGNOSIS; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONFERENCE PAPER; EXERCISE; HEART LEFT VENTRICLE FAILURE; HUMAN; LONG TERM CARE; LONGITUDINAL STUDY; PATIENT SELECTION; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING; TREATMENT INDICATION;

ANTHRACYCLINES; CARDIOMYOPATHIES; CLINICAL TRIALS; EXERCISE THERAPY; HUMANS; NEOPLASMS; SURVIVORS;

EID: 18244396920     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20354     Document Type: Conference Paper

References (25)

1. Silber JH, Cnaan A, Clark BJ, et al. Design and baseline characteristics for the ACE inhibitor after anthracycline: A study of cardiac dysfunction in long-term pediatric cancer survivors. Am Heart J 2001;142:577-585.
2. Smets EMA, Garssen B, Schuster-Uitterhove ALJ, et al. Fatigue in cancer patients. Br J Cancer 1993;68:220.
3. Irvine DM, Vincent L, Graydon J, et al. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with fatigue experienced by healthy individuals. Cancer Nurs 1994;17:367.
4. Marx M, Langer T, Graf N, et al. Multicenter analysis of anthracycline-induced cardiotoxicity in children following treatment according to the nephroblastoma studies SIOP No.9/GPOH and SIOP 93-01/GPOH. Med Pediatr Oncol 2002;39:18-24.
5. Johnson D, Perrault H, Fournier A, et al. Cardiovascular responses to dynamic submaximal exercise in children previously treated with anthracycline. Am Heart J 1997;133:169-173.
6. Winningham ML, Nail LM, Barton Burke M, et al. Fatigue and the cancer experience: The state of the knowledge. Oncol Nurse Forum 1994;21:23.
7. Sung RYT, Huang GY, Shing MK, et al. Echocardiographic evaluation of cardiac function in paediatric oncology patients treated with or without anthracycline. Int J Cardiol 1997;60:239-248.
8. Green PS, Leeuwenburgh C. Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis. Biochimica et Biophysica Acta 2002;1588:94-101.
9. Lebrecht D, Setzer B, Ketelsen UP, et al. Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy. Circulation 2003; 108:2423-2429.
10. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991;324:808-815.
11. Bristow MR, Billingham ME, Mason JW. Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep 1978;62: 873-879.
12. Weesner KM, Bledsoe M, Chauvenet A, et al. Exercise echocardiography in the detection of anthracycline cardiotoxicity. Cancer 1991;68:435-438.
13. Fletcher GF, Balair SN, Blumenthal J, et al. Statement on exercise: Benefits and recommendations for physical activity programs for all Amercans: A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation 1992;86:340-344.
14. NIH Consensus Development Panel on Physical Activity and Cardiovascular Health. Physical activity and cardiovascular health. JAMA 1996;276:241-246.
15. Balady GJ, Araujo CG, Thompson PD, et al. Recommendations for cardiovascular screening, staffing, and emergency policies at health/fitness facilities. Circulation 1998;97:2283-2293.
16. Druck MN, Gusenchyn WH, Evans WK, et al. Radionuclide angiography and radionuclide case endomyocardial biopsy in the assessment of doxorubicin cardiotoxicity. Cancer 1984;53:1667-1674.
17. Lang D, Hilger F, Binswanger J, et al. Late effects of anthracycline therapy in childhood in relation to the function of the heart at rest and under physical stress. Eur J Pediatr 1995;154:340-345.
18. Ganz WI, Sridhar KS, Gonzalez R, et al. Review of tests for monitoring doxorubicin-induced cardiomyopathy. Oncology 1996; 53:461-470.
19. Hauser M, Gibson BS, Wilson N. Diagnosis of anthracycline-induced late cardiomyopathy by exercise-spiroergometry and stress-echocardiography. Eur J Pediatr 2001;160:607-610.
20. Weglicki WB, Bloom S, Cassidy MM, et al. Antioxidants and the cardiomyopathy of MG deficiency. Am J Cardiovasc Pathol 1992;4:210-215.
21. Larsen RJ, Jakacki RJ, Vetter VL, et al. Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults. Am J Cardiol 1992;70:73-77.
22. Sharkey AM, Carey AB, Heise CT, et al. Cardiac rehabilitation after cancer therapy in children and young adults. Am J Cardiol 1993;71:1488-1490.
23. Calaminus G, Kiebert G. Studies on health-related quality of life in childhood cancer in the european setting: An overview. Int J Cancer 1999;12:83-86.
24. Vizinova H, Malincikova J, Klaskova E, et al. Exercise cardiorespiratory parameters in children. Cas Lek ces (J Czech Doctors) 2002;141:491-493.
25. ACSM guidelines for exercise testing and prescription, 5th edn. Baltimore: Williams & Wilkins; 1995. pp 98-100.